BRNO, CZECH REPUBLIC, April 17, 2023 – ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust supply chain and support systems.

SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr. Allen will assume leadership of all aspects of the ALPCO-GeneProof organization in the United States and Europe.

In April of this year, ALPCO proudly announced its merger with GeneProof. Together we are a global leader in immunodiagnostics and molecular diagnostics providing you, our customers, with reagents and proprietary automated sample-to-answer solutions for the tests that matter most to you. Through the depth and breadth of our respective portfolios, ALPCO and GeneProof provide you with t...

Skip the crowd! Reserve you own one-on-one appointment at AACC for a personalized demo. Schedule here. Featuring New and Exclusive Automated Platforms for Molecular Dx myCROBE is your PCR Laboratory on the Table A fully automated sample-to-result solution for molecular diagnostics with a broad spectrum of diagnostic tests. croBEE 2.0 Nucleic Acid Extraction System is a...

SALEM, NH and BRNO, Czech Republic – April 21st, 2022: American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader in the diagnostic products market, with broad capabilities spanning ...

FOR IMMEDIATE RELEASE – ALPCO’s Winter 2022 Diabetes Research Travel Grant has been awarded to Anoop Arunagiri, PhD, a Research Investigator at the University of Michigan.

Dr. Arunagiri’s research is centered on studying proinsulin misfolding in pancreatic beta cells, and delineating the events and factors contributing to misfolding in the context of diabetes.

ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an unlimited match to all its employees’ contributions to humanitarian aid organizations. As of March 14, ...

FOR IMMEDIATE RELEASE Salem, NH – February 1, 2022: ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to prop...

Salem, NH, October 12, 2021 [caption id="attachment_7170" align="alignleft" width="229"] Mollie Huber, Summer 2021 Diabetes Research Travel Grant Recipient[/caption] FOR IMMEDIATE RELEASE – ALPCO’s Summer 2021 Diabetes Research Travel Grant has been awarded to Mollie Huber, a fourth year PhD candidate in the Biomedical Sciences program at the University of Florida. Mollie’s novel resea...

We’re excited to announce that ALPCO will be exhibiting at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo at the Georgia World Congress Center in Atlanta, GA from September 28-30. We will be showcasing our growing menu of clinical test kits at booth 3431. Stop by to learn more about an exclusive AACC evaluation promotion for stool-based GI biomarker kits which includes two free...